Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1988-6-16
|
pubmed:abstractText |
The affinities of 34 adrenergic antagonists for alpha-2 adrenergic receptors were determined from homogenate radioligand binding studies using [3H]yohimbine and [3H]rauwolscine. It has been suggested that alpha-2 adrenergic receptors can be subdivided into alpha-2A and alpha-2B subtypes. Oxymetazoline is selective for alpha-2A receptors, whereas prazosin is alpha-2B selective. Five different tissues were used, each of which has only one of the two subtypes: human platelet (alpha-2A), HT29 cell line (alpha-2A), human cerebral cortex (alpha-2A), neonatal rat lung (alpha-2B), and NG108-15 cell line (alpha-2B). The drug affinities were highly correlated when alpha-2A tissues were compared with alpha-2A tissues (r = 0.97 to 0.98) or when the two alpha-2B tissues were compared (r = 0.99). By contrast, comparison of an alpha-2A tissue with an alpha-2B tissue resulted in poor correlations (r = 0.77 to -0.87). Three new subtype selective drugs were identified among these drugs on the basis of at least a 10-fold greater affinity for one subtype. All three were selective for the alpha-2B subtype: ARC-239 (100-fold selective), chlorpromazine (18-fold selective), and 7-hydroxychlorpromazine (17-fold selective). These studies, by demonstrating distinct pharmacological profiles for the two alpha-2 adrenergic receptor subtypes in several different tissues, further support the existence and definition of these subtypes. The identification of a cell line for each subtype should be useful in the further study of alpha-2 adrenergic receptor subtypes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
245
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
600-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2835476-Animals,
pubmed-meshheading:2835476-Binding, Competitive,
pubmed-meshheading:2835476-Blood Platelets,
pubmed-meshheading:2835476-Brain,
pubmed-meshheading:2835476-Cell Line,
pubmed-meshheading:2835476-Female,
pubmed-meshheading:2835476-Humans,
pubmed-meshheading:2835476-Kinetics,
pubmed-meshheading:2835476-Lung,
pubmed-meshheading:2835476-Male,
pubmed-meshheading:2835476-Organ Specificity,
pubmed-meshheading:2835476-Prazosin,
pubmed-meshheading:2835476-Rats,
pubmed-meshheading:2835476-Rats, Inbred Strains,
pubmed-meshheading:2835476-Receptors, Adrenergic, alpha,
pubmed-meshheading:2835476-Receptors, Adrenergic, beta,
pubmed-meshheading:2835476-Yohimbine
|
pubmed:year |
1988
|
pubmed:articleTitle |
Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype.
|
pubmed:affiliation |
Department of Pharmacology, School of Medicine, University of Missouri, Columbia.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|